KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Accumulated Expenses (2016 - 2018)

NovoCure's Other Accumulated Expenses history spans 5 years, with the latest figure at $32000.0 for Q4 2018.

  • On a quarterly basis, Other Accumulated Expenses fell 77.78% to $32000.0 in Q4 2018 year-over-year; TTM through Dec 2018 was $32000.0, a 77.78% decrease, with the full-year FY2018 number at $32000.0, down 77.78% from a year prior.
  • Other Accumulated Expenses hit $32000.0 in Q4 2018 for NovoCure, down from $144000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for NVCR hit a ceiling of $712000.0 in Q4 2015 and a floor of $32000.0 in Q4 2018.
  • Historically, Other Accumulated Expenses has averaged $212200.0 across 5 years, with a median of $97000.0 in 2014.
  • Biggest five-year swings in Other Accumulated Expenses: soared 634.02% in 2015 and later plummeted 89.33% in 2016.
  • Tracing NVCR's Other Accumulated Expenses over 5 years: stood at $97000.0 in 2014, then soared by 634.02% to $712000.0 in 2015, then plummeted by 89.33% to $76000.0 in 2016, then surged by 89.47% to $144000.0 in 2017, then crashed by 77.78% to $32000.0 in 2018.
  • Business Quant data shows Other Accumulated Expenses for NVCR at $32000.0 in Q4 2018, $144000.0 in Q4 2017, and $76000.0 in Q4 2016.